We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 529

New drug law in Canada

  • Shook Hardy & Bacon LLP
  • -
  • Canada
  • -
  • November 17 2014

With a tip of the cap to our old friend, Peter Pliszka, north of border: Earlier this month, the so-called Protecting Canadians from Unsafe Drugs Act

Class actions and consumer product settlements: the proof is in (the receipt for) the pudding

  • Osler Hoskin & Harcourt LLP
  • -
  • Canada, USA
  • -
  • November 14 2014

Consumers don’t keep their receipts. This poses a unique challenge in consumer product class actions, especially when parties seek the Court’s

Changes to Food and Drugs Act address patient safety passage of Vanessa’s Law

  • Miller Thomson LLP
  • -
  • Canada
  • -
  • November 13 2014

Bill C-17, the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) was passed by the federal legislature and received Royal Assent on November

Government of Canada finalizes plain language drug labelling regulations

  • Baker & McKenzie
  • -
  • Canada
  • -
  • November 11 2014

On July 2, 2014, the Canadian Minister of Health announced the finalization of amendments to regulations under the Food and Drugs Act which, as

Supreme Court of Canada denies leave to non- injured plaintiffs seeking restitutionary remedies under the BPCPA and Competition Act

  • Baker & McKenzie
  • -
  • Canada
  • -
  • November 11 2014

On September 4, 2014, the Supreme Court of Canada (the “Supreme Court”) dismissed the plaintiffs’ motion for leave to appeal in a proposed class

Proposed “patient safety” legislation to give Health Canada heightened powers

  • Baker & McKenzie
  • -
  • Canada
  • -
  • November 11 2014

Bill C-17, An Act to Amend the Food and Drugs Act,1 was introduced by Canada's Minister of Health, Rona Ambrose, on December 6, 2013. Many

Bill C-17 (Vanessa’s Law) receives Royal Assent

  • Stikeman Elliott LLP
  • -
  • Canada
  • -
  • November 11 2014

Bill C-17, An Act to Amend the Foods and Drugs Act (Vanessa's Law) has received Royal Assent and will come into force on a date to be fixed by

Vanessa’s Law enacted by Parliament - a new chapter in drug and device enforcement in Canada

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada
  • -
  • November 10 2014

On November 6, 2014, the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) received Royal Assent andbecame law in Canada. This new

Disclosure of clinical trial and other information: recent developments in Canada and the EU

  • Norton Rose Fulbright LLP
  • -
  • Canada, European Union
  • -
  • November 10 2014

Bill C-17, An Act to Amend the Food and Drugs Act, reported in our earlier Pharma In Brief has now passed through Parliament and was given Royal

B.C. Court denies certification of vitaminwater class action

  • Osler Hoskin & Harcourt LLP
  • -
  • Canada
  • -
  • November 6 2014

The British Columbia Supreme Court recently denied certification of a proposed class action regarding the labelling and marketing of vitaminwater